BioSpace News Archive

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

The American Cancer Society is proud to announce the addition of four stellar community leaders to join the Illinois Area Board. Ken Hallman, John Greene, Carlos Cata, and Megan McNerney, M.D., Ph.D.

Oncology Pharma Inc. (OTC: ONPH) is pleased to announce that it has executed a world-wide Licensing Agreement with Sybleu Inc. for its Cancer therapy by intratumoral injection of a chemotherapeutic agent in combination with a bioactive immunostimulatory agent.

Company sponsors #wewearstripes social media campaign calling on participants to share photos to express support for people affected by rare diseases

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) highlights results from the in vitro study “Migraine Therapeutics Differentially Modulate the CGRP Pathway,” which were published online by Cephalalgia, a monthly journal published on behalf of the International Headache Society.

bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the Cowen 41st Annual Health Care Conference, Wednesday, March 3, at 2:40 p.m. ET.

Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that management will participate in two upcoming investor conferences:

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, joins the rare disease community in support of Rare Disease Day 2021.

In the year since the World Health Organization declared COVID-19 a global pandemic, tens of thousands of Americans have stepped up to address the needs of those reeling from the pandemic as well as record-breaking disasters across the country.

BioLife Sciences (OTCPK: BLFE) announces the launch of their Copper-Infused Face Masks to provide consumers with the long-lasting health and protective benefits of antimicrobial copper, which is infused throughout the fabric using NanoFusion Technology